# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-032516
Filing Date
2023-04-25
Accepted
2023-04-25 16:28:42
Documents
8
Period of Report
2023-06-07

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROXY STATEMENT | def14a0423_optimizerxcorp.htm | DEF 14A | 1339460
2 | GRAPHIC | tbarchart_001.jpg | GRAPHIC | 283036
3 | GRAPHIC | tbarchart_002.jpg | GRAPHIC | 317620
4 | GRAPHIC | timage_001.jpg | GRAPHIC | 205077
5 | GRAPHIC | timage_002.jpg | GRAPHIC | 396142
6 | GRAPHIC | toprx_logo.jpg | GRAPHIC | 46776
7 | GRAPHIC | tproxy_001.jpg | GRAPHIC | 1049246
8 | GRAPHIC | tproxy_002.jpg | GRAPHIC | 820247
| Complete submission text file | 0001213900-23-032516.txt |  | 5636497

Mailing Address 400 WATER ST., STE. 200 ROCHESTER MI 48307
Business Address 400 WATER ST., STE. 200 ROCHESTER MI 48307 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

EIN.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38543 | Film No.: 23845242
SIC: 7389 Services-Business Services, NEC